Pharmaceutical formulations
PT4527467TActive Publication Date: 2026-06-01GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PT2024216441T
- Authority / Receiving Office
- PT · PT
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-04-01
- Filing Date
- 2016-06-29
- Publication Date
- 2026-06-01
- Estimated Expiration
- 2036-06-29
Abstract
The invention provides a solid oral dosage form comprising tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art